Infinium Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0MRE01011
  • NSEID: INFINIUM
  • BSEID:
INR
239.80
-2.2 (-0.91%)
BSENSE

Dec 05

BSE+NSE Vol: 500

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Infinium Pharmachem Ltd stock-summary
stock-summary
Infinium Pharmachem Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Infinium Pharmachem Limited was originally incorporated as "Infinium Pharmachem Private Limited" on November 21, 2003 issued by the Registrar of Companies, Gujarat. Later on, Company converted its status into Public Company and the name of Company was changed to "Infinium Pharmachem Limited" vide fresh Certificate of Incorporation dated August 12, 2022. Company is engaged in manufacturing and selling of Iodian based Pharmaceutical Intermediates . The Company has its manufacturing plant at Dist.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 13.92 Cr
Number of Shares
1.39 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
13-Sep-2023
1.39
13.92
6958060
10
Bonus Issue
11-Apr-2023
69.58
6.96
1875000
10
Public Issue
25-Jun-2022
50.83
5.08
4066448
10
Bonus Issue
16-Mar-2018
10.17
1.02
508306
10
Bonus Issue
27-Mar-2017
5.08
0.51
73801
10
Right Issues
29-Mar-2014
4.35
0.43
70505
10
Right Issues
20-Mar-2014
3.64
0.36
134000
10
Right Issues
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Pravin Bhadabhai Madhani (21.66%)

Highest Public shareholder

Madhani Krunal Pravinbhai (5%)

Individual Investors Holdings

37.21%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
Sanjaykumar Viththalbhai Patel
Chairman & Managing Director
55.0 lacs
Pravin Bhadabhai Madhani
Executive Director
55.0 lacs
Mitesh Lavjibhai Chikhaliya
Executive Director
55.0 lacs
Keyur Shah
Independent Director
25.0 k
Tarun Ratilal Dobariya
Independent Director
25.0 k
Vaishakhi Ambrishbhai Shukla
Independent Director
25.0 k
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR Cr (Micro Cap)

stock-summary
P/E

45.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

0.00